<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zdor</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы здоровья и экологии</journal-title><trans-title-group xml:lang="en"><trans-title>Health and Ecology Issues</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2220-0967</issn><issn pub-type="epub">2708-6011</issn><publisher><publisher-name>Gomel State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.51523/2708-6011.2011-8-3-19</article-id><article-id custom-type="elpub" pub-id-type="custom">zdor-1136</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>РАЗРАБОТКА ПРИНЦИПОВ СОЗДАНИЯ ДИАГНОСТИЧЕСКОГО НАБОРА ДЛЯ ОПРЕДЕЛЕНИЯ ЛЕКАРСТВЕННОЙ ЧУВСТВИТЕЛЬНОСТИ ЛЕЙКОЗНЫХ КЛЕТОК</article-title><trans-title-group xml:lang="en"><trans-title>DEVELOPMENT OF THE PRINCIPLES TO CREATE A DIAGNOSTIC KIT TO ASSESS DRUG SENSITIVITY OF leukemIC cells</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Свирновский</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Svirnovskiy</surname><given-names>A. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сергиенко</surname><given-names>Т. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Sergiyenko</surname><given-names>T. F.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пасюков</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pasiukov</surname><given-names>V. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тарас</surname><given-names>И. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Taras</surname><given-names>I. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бакун</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bakun</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Василевич</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasilevich</surname><given-names>A. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стежкин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Stezhkin</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дрейчук</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dreichuk</surname><given-names>N. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алейникова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Aleinikova</surname><given-names>O. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шман</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shman</surname><given-names>T. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнова</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnova</surname><given-names>L. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колбаско</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolbasko</surname><given-names>L. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Республиканский научно-практический центр гематологии и трансфузиологии</institution></aff><aff xml:lang="en"><institution>Republican Research Center for Hematology and Transfusiology</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Республиканский научно-практический центр детской онкологии и гематологии</institution></aff><aff xml:lang="en"><institution>Republican Research Center for Pediatric Oncology and Hematology</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Белорусская медицинская академия последипломного образования</institution></aff><aff xml:lang="en"><institution>Belarussian Medical Academy of Postgraduate Education</institution></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>9-я городская клиническая больница</institution></aff><aff xml:lang="en"><institution>Municipal Clinical Hospital No. 9</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>28</day><month>09</month><year>2011</year></pub-date><volume>0</volume><issue>3</issue><fpage>94</fpage><lpage>100</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Свирновский А.И., Сергиенко Т.Ф., Пасюков В.В., Тарас И.Б., Бакун А.В., Василевич А.С., Стежкин А.В., Дрейчук Н.А., Алейникова О.В., Шман Т.В., Смирнова Л.А., Колбаско Л.В., 2011</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="ru">Свирновский А.И., Сергиенко Т.Ф., Пасюков В.В., Тарас И.Б., Бакун А.В., Василевич А.С., Стежкин А.В., Дрейчук Н.А., Алейникова О.В., Шман Т.В., Смирнова Л.А., Колбаско Л.В.</copyright-holder><copyright-holder xml:lang="en">Svirnovskiy A.I., Sergiyenko T.F., Pasiukov V.V., Taras I.B., Bakun A.V., Vasilevich A.S., Stezhkin A.V., Dreichuk N.A., Aleinikova O.V., Shman T.V., Smirnova L.A., Kolbasko L.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.gsmu.by/jour/article/view/1136">https://journal.gsmu.by/jour/article/view/1136</self-uri><abstract><p>Для определения ответа клеток на противолейкозные препараты in vitro в концентрации, близкой к терапевтической в крови, предложен диагностический набор, который включает панель лиофилизированных лекарственных средств, с помощью которой можно сравнить чувствительность лейкозных клеток пациента к различным препаратам.</p></abstract><trans-abstract xml:lang="en"><p>To assess the response of cells to antileukemic drugs in vitro in the concentration, similar to the therapeutic in blood, a diagnostic kit has been suggested to switch the panel of frozen-dried drugs that can help to compare the sensitivity of the patient`s leukemic cells to different preparations.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>лейкоз</kwd><kwd>химиочувствительность клеток</kwd><kwd>диагностика</kwd><kwd>набор реагентов</kwd><kwd>leukemia</kwd><kwd>chemosensitivity of cells</kwd><kwd>diagnostics</kwd><kwd>reagent kit</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Flow cytometric chemosensitivity assay as a predictive tool of early clinical response in acute lymphoblastic leukemia / F. Galderisi [et al.] // Pediatric Blood Cancer. - 2009. - Vol. 53, № 4. - P. 543-550.</mixed-citation><mixed-citation xml:lang="en">Flow cytometric chemosensitivity assay as a predictive tool of early clinical response in acute lymphoblastic leukemia / F. Galderisi [et al.] // Pediatric Blood Cancer. - 2009. - Vol. 53, № 4. - P. 543-550.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Relationship between in virto chemosensitivity assessed with MTT assay in clinical outcomes in 103 patients with acute leukemia / K. R. Jun. [et al.] // Korean J Lab Med. - 2007. - Vol. 27, № 2. - P. 89-95.</mixed-citation><mixed-citation xml:lang="en">Relationship between in virto chemosensitivity assessed with MTT assay in clinical outcomes in 103 patients with acute leukemia / K. R. Jun. [et al.] // Korean J Lab Med. - 2007. - Vol. 27, № 2. - P. 89-95.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Clinical relevance of in vitro chemoresistance in childhood acute myeloid leukemia / S. Yamada [et al.] // Leukemia. - 2001. - Vol. 15. - P. 1892-1897.</mixed-citation><mixed-citation xml:lang="en">Clinical relevance of in vitro chemoresistance in childhood acute myeloid leukemia / S. Yamada [et al.] // Leukemia. - 2001. - Vol. 15. - P. 1892-1897.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Prediction of clinical response to chemotherapy by in vitro chemosensitivity assay in acute leukemia / A. L. Dogan [et al.] // Turkish Journal of Cancer. - 2004. - Vol. 34, № 2. - P. 75-80.</mixed-citation><mixed-citation xml:lang="en">Prediction of clinical response to chemotherapy by in vitro chemosensitivity assay in acute leukemia / A. L. Dogan [et al.] // Turkish Journal of Cancer. - 2004. - Vol. 34, № 2. - P. 75-80.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bosanquet, A. G. Individualized tumor response testing in leukemia and lymphoma / A. G. Bosanquet, P. Nygren, L. M. Weisenthal // In: G. J. Kaspers, eds. Innovate leukemia and lymphoma therapy. New York: Informa Healthcare. - 2008. - P. 23-43.</mixed-citation><mixed-citation xml:lang="en">Bosanquet, A. G. Individualized tumor response testing in leukemia and lymphoma / A. G. Bosanquet, P. Nygren, L. M. Weisenthal // In: G. J. Kaspers, eds. Innovate leukemia and lymphoma therapy. New York: Informa Healthcare. - 2008. - P. 23-43.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Лекарственная чувствительность лейкозных клеток ex vivo и прогнозирование ответа пациентов с ХЛЛ на терапию / А. И. Свирновский [и др.] // Здравоохранение. - 2010. - № 3. - С. 57-60.</mixed-citation><mixed-citation xml:lang="en">Лекарственная чувствительность лейкозных клеток ex vivo и прогнозирование ответа пациентов с ХЛЛ на терапию / А. И. Свирновский [и др.] // Здравоохранение. - 2010. - № 3. - С. 57-60.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Свирновский, А. И. Биологические свойства лейкозных клеток и клинический фенотип при хроническом лимфоцитарном лейкозе / А. И. Свирновский / Гематология и трансфузиология. - 2010. - № 1. - С. 25-32.</mixed-citation><mixed-citation xml:lang="en">Свирновский, А. И. Биологические свойства лейкозных клеток и клинический фенотип при хроническом лимфоцитарном лейкозе / А. И. Свирновский / Гематология и трансфузиология. - 2010. - № 1. - С. 25-32.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Анализ чувствительности лейкемических клеток к химиопрепаратам при остром лимфобластном лейкозе у детей по результатам МТТ-теста ex vivo / Т. А. Астрелина [и др.] // Гематология и трансфузиология. - 2002. - № 4. - С. 3-7.</mixed-citation><mixed-citation xml:lang="en">Анализ чувствительности лейкемических клеток к химиопрепаратам при остром лимфобластном лейкозе у детей по результатам МТТ-теста ex vivo / Т. А. Астрелина [и др.] // Гематология и трансфузиология. - 2002. - № 4. - С. 3-7.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kaspers, G. J. L. Use of the differential staining cytotoxicity assay to predict chemosensitivity / G. J. L. Kaspers // Methods in molecular medicine. - 2005. - Vol. 110. - P. 49-57.</mixed-citation><mixed-citation xml:lang="en">Kaspers, G. J. L. Use of the differential staining cytotoxicity assay to predict chemosensitivity / G. J. L. Kaspers // Methods in molecular medicine. - 2005. - Vol. 110. - P. 49-57.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derovvatives / D. Bron [et al.] // Investigational New Drugs. - 2010. - Vol. 4, № 1. - P. 11-16.</mixed-citation><mixed-citation xml:lang="en">Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derovvatives / D. Bron [et al.] // Investigational New Drugs. - 2010. - Vol. 4, № 1. - P. 11-16.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy / M. Ragusa [et al.] // BMC Cancer. - 2010. - Vol. 10. - P. 377-391.</mixed-citation><mixed-citation xml:lang="en">Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy / M. Ragusa [et al.] // BMC Cancer. - 2010. - Vol. 10. - P. 377-391.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Variability in resposivenes to lovastin of the primitive CD34+ AML subfraction compared to normal CD34+ cells / S. D. P. W. M.de Joge Peeters [et al.] // Ann Hematol. - 2009. - Vol. 88. - P. 573-580.</mixed-citation><mixed-citation xml:lang="en">Variability in resposivenes to lovastin of the primitive CD34+ AML subfraction compared to normal CD34+ cells / S. D. P. W. M.de Joge Peeters [et al.] // Ann Hematol. - 2009. - Vol. 88. - P. 573-580.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bosanquet, A. G. Laboratory tests of cytotoxic drug sensitivity / A. G. Bosanquet // Biomedical Scientist. - 2007. - Vol. 51. - P. 432-435.</mixed-citation><mixed-citation xml:lang="en">Bosanquet, A. G. Laboratory tests of cytotoxic drug sensitivity / A. G. Bosanquet // Biomedical Scientist. - 2007. - Vol. 51. - P. 432-435.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Sargent, J. M. The use of the MTT assay to study drug resistance in fresh tumour samples / J. M. Sargent // Recent Results Cancer Res. - 2003. - Vol. 161. - P. 13-25.</mixed-citation><mixed-citation xml:lang="en">Sargent, J. M. The use of the MTT assay to study drug resistance in fresh tumour samples / J. M. Sargent // Recent Results Cancer Res. - 2003. - Vol. 161. - P. 13-25.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukemia by an inhanced method of individualized tumor response testing / A. G. Bosanquet [et al.] // British Journal of Hematology. - 2009. - Vol. 146, № 4. - P. 384-395.</mixed-citation><mixed-citation xml:lang="en">Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukemia by an inhanced method of individualized tumor response testing / A. G. Bosanquet [et al.] // British Journal of Hematology. - 2009. - Vol. 146, № 4. - P. 384-395.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
